Similarly, in the prediction model developed by Guo et al. Her-2 status, ER expression level, response in the breast, and clinical stage at diagnosis were recognized as independent predictors of nodal pCR in hormone receptor positive breast cancer patients [31]. This evidence concerns the gene NR4A1 and breast carcinoma.